chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Doctor had the 1st dose last 16Dec2020 then tested positive for COVID 17Dec2020; Doctor had the 1st dose last 16Dec2020 then tested positive for COVID 17Dec2020; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect, received from a contactable physician (patient). A male patient of an unspecified age started to the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), unspecified route of administration on 16Dec2020 as a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The physician inquired "is it recommended to receive the 2nd dose despite having antibodies and recovered from COVID?"  The doctor had the 1st dose on 16Dec2020 then tested positive for COVID 17Dec2020. He will receive the 2nd dose tomorrow 06Jan2021 and he was recovering.  The patient underwent lab tests and procedures which included COVID test: result positive on 17Dec2020.   Outcome of the event doctor had the 1st dose last 16Dec2020 then tested positive for COVID 17Dec2020 was recovering.  Information on the lot/batch number has been requested.; Sender's Comments: The reported tested positive for COVID  after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.
Pt. received PROQUAD and Hep A vaccine on 6/12/15. Parents report fever to 104 that started on 6/14/15. Saw Dr. on 6/15/15. Exam by MD and labs drawn. 6/18/15 Fever subsided and no more symptoms.
Patient state that she alway experiences symptoms after receiving shots.  Chief compliant was headache, chills with body aches and nausea and vomiting.  These symptoms were still occurring on day 2 when I interviewed the patient.
Child c/o nausea apx 10 minutes after injection, observed pallor, unsteady gait, became weak and was assisted to the floor, RR22-24, other VSS.  Did not lose consciousness but was quite weak
Redness, swelling. Developed cellulitis by Sunday evening. Hot to touch. Cellulitis progressed to elbow and to shoulder. Saw NP on monday. Prescribed Clindamycin 300 3 times a day for 7 days.
At 3am I had a horrible pain, I had never felt on the left side, as if went through my chest. A sharp pain that went all over my left arm, neck and face and after, a sharp cramp pain in the abdomen like colic. I took aspirin and had pain for half and hour, later it decreased but I still have mild pain, like when I exercise. Numbness in the face neck shoulder, arm and hand. Today I have an electrocardiogram and Monday with my doctor since being the weekend they do not have consultations.
This spontaneous report was received from a physician via a company representative referring to a 14 month old female patient. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 01-JUN-2017, during the same appointment, the patient was vaccinated with a dose of M-M-R II subcutaneouslly, lot # M028130, expiration date on 03-JUN-2018(strength, dose number and anatomical location were not provided) for prophylaxis and a dose of PROQUAD lot # M041084, expiration date on 04-APR-2018. It was reported that the patient received PROQUAD in error, instead of VARIVAX, however no adverse events were reported. It was reported that no treatment was given.      Additional information has been requested.
Cough (mild - no trouble breathing) & Diarrhea 1.30 / chills 1.31 / leg & back pains 1.31-2.1 / continuing cough
Pt had chills lasting 50 minutes the night of the vaccination and fever as high as 103 for 3 hours. Pt reports still feeling bad with no improvement seen until 12/9/18.
Dose #3 administered at 5-5:30pm.  Pt woke up in the middle of the night complaining of bilateral shoulder numbness.  The numbness was gone by morning.  Pt reported info to MD.  MD advised him to report symptoms to Public Health and Env Services.  Advised pt again to ask MD to report symptoms since additional information regarding vaccine administration is unknown.
Acute anxiety; Adverse effect of COVID-19 vaccine; Heart palpitations; Numbness and tingling of right arm and leg
Patient requested M-M-R vaccine and was suppose to be VARIVAX. MD okay'd getting both vaccines.
Approx 20 min after my flu shot, I developed chest tightness, itching of my throat, tongue and lips and selling. If my to gue
No adverse events until 5 days after. Site is now red, hot to touch, swollen, and itchy and seems to be getting worse.
I had near fainting episodes; I felt very sick and I felt like I was gonna faint and it went away then it came back and I felt awful.
This 26 year old was referred for site reaction after receipt of AVA vaccine and assistance in VAERS filing. Prior AVA vaccines were given 1/11/11, 2/11/11, 7/12/11, and 6/18/12 with soreness to site and arm for 1-2 days. He received AVA #5 to left deltoid on 12/17/12 (AVA FAV 309) - this was given 6 months from previous dose (per AVA schedule).  He denied any trauma, exercising or injury to left deltoid. Approximately 24 hours after receipt of AVA vaccine, the vaccine site began to itch. On day 2 (12/19/12) the vaccine site had a "2.5 inch circular red raised rash".  He presented to medical and was diagnosed with urticaria lesion to left shoulder. Pt had not been taking any medication for the itching or site redness and advised provider he did not want/require Benadryl or topical steroid cream at this time (does not like to take medication unless needed). Pt advised on 12/20/12 the sited was still red but not as severe as yesterday. (Picture sent by pt...see below). Denied any contact with new clothing, detergents, deodorants, soaps, was not hiking, around animals, no new foods, no recent exercise/trauma to arm.
Broke out in hives on left lower arm about 2 hours after receiving H1N1 flu mist.  Took Benadryl po and hives cleared.
This case was reported by a consumer and described the occurrence of injection site pain in a 61-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medications included LAMICTAL, WELLBUTRIN and ACTONEL. On 28 October 2010 the subject received 1st dose of FLULAVAL (unknown, left arm). On 28 October 2010, immediately after vaccination with FLULAVAL, the subject experienced pain, redness, swelling and hotness at the injection site. She also noticed that she developed difficulty raising and moving her left arm and loss of mobility. The subject stated that she was concerned about the injection site because the nurse vaccinated her below the deltoid where the biceps and triceps meet in front of her arm. She believed that was about four inches lower than it was supposed to be located. These symptoms continued for several months and gradually began to improve around February 2011 and completely resolved July 2011. On an unspecified date in July 2011, the pain, redness, swelling and hotness at the injection site, difficulty raising and moving her left arm and loss of mobility resolved. The subject refused to be contacted for follow-up.
This spontaneous report as received from a nurse refers to a 11 year old patient of unknown gender who on approximately on December 2013 (within the last month or two), was vaccinated with the first dose of GARDASIL dose 1 (Dose, route and lot number was not provided). The reporter informed that the patient experienced that they "felt funny" and then had a seizure, after receiving the "eleven year old shots" which included the first dose of GARDASIL, "within the last month or two." The patient was sent to the Hospital, as per the office protocol. The patient did not required intervention to prevent serious criteria. At the time of the report the patient was well. The outcome of had a seizure, after receiving their first dose of GARDASIL and felt funny was unknown. Upon internal review, the event of seizure was considered as medically significant. The relationship between adverse events and GARDASIL was unknown. This is one of two reports from the same source. Additional information has been requested.
Fifteen Month Old female patient received three immunizations - it was not noted that the expiration date on the viral had expired until nurse went to document in patient's chart. The State Department for Immunization was contacted immediate for direction.
Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on 2/27/2021 and 3/27/2021. Patient presented to ED for respiratory distress. Patient DNI on arrival and transitioned to DNR/COT. Patient received dexamethasone, zosyn, and remdesivir with plans to transfer home for hospice in the morning. Patient required BiPAP and became hypotensive. Patient desaturated and decompensated upon trying to transfer home. Patient expired 1/21/2022 at 1945.
Drug ineffective; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old male patient received BNT162b2 (BNT162B2 NOS), on 11Oct2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 42 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Barrett's esophagus" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown"; COVID-19 (medically significant), outcome "unknown", described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: Tested negative 9 days after initial symptoms. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300178136 same patient/product, different dose/event;
Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Rash (other than injection site)-Mild, Systemic: severe itching
Patient passed out in store about 1 hour after his vaccines.  Patient was assessed by EMS and it was determined patient had only eaten noodles a few hours before vaccines and was light-headed due to not having eating in combination with vaccines. Patient left with parents on his own accord.
Headache and joint pain, myalgias, leukocytosis, pain/swelling/erythema at deltoid where PNEUMOVAX administered. Ceftriaxone 2 gm BID, acyclovir 500 mg once, dexamethasone 4 mg every day.
Within 24 hours of receiving the vaccination, the patient developed a verbal tic.  The verbal tic has gotten progressively worse over the course of the following six weeks and now includes motor and verbal tics in addition to sleep disruption and frequent mood swings and emotional outbursts.
Vaccine was administered at 2:05pm on 02/02/2021.  At 6:00pm EST my mouth felt odd as if I burned my palate.  After 48 hours the feeling did not subside so I made an appointment to visit my oral surgeon.  On 02/04/2021 I visited my oral surgeon who took  multiple pictutes of my mouth/palate and felt it was a reaction to the vaccine.  She prescribed a mouthwash as treatment and a follow up in 2 weeks.
her arm broke out with big red things; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (her arm broke out with big red things) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (her arm broke out with big red things). At the time of the report, RASH ERYTHEMATOUS (her arm broke out with big red things) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   Most recent FOLLOW-UP information incorporated above includes: On 10-Aug-2021: Live Follow-up
Worsen neuropathic symptoms; migraine headache; Sore arm; fatigue; low grade fevers; chilled; This is a spontaneous report from a contactable consumer(patient).   This is the 1st of 2 reports, for the Second dose.   A 43-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 on 24Mar2021 (at age of 43 years old) 11:45AM, via an unspecified route of administration, administered in Arm Left (Batch/Lot number was not reported) at single dose, for covid-19 immunisation.  Medical history included Ovarian cancer, blood clots, hypertension. known allergies Salfa. The patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 on 03Mar2021 (at age of 43 years old)  11:00 AM, via an unspecified route of administration, administered in Arm Left (Batch/Lot number was not reported) at single dose, for covid-19 immunisation and experienced Sore arm, Worsen neuropathic symptoms (existing side effects from chemo) - pains on fingers, wrists, feet, toes, back# fatigue, migraine headache for 15 days. Concomitant medication(s) in two weeks included duloxetine hydrochloride (CYMBALTA) 30 mg, warfarin 1mg and hydrochlorothiazide, all taken for an unspecified indication, start and stop date were not reported. Sore arm, Worsen neuropathic symptoms (existing side effects from chemo) - pains on fingers, wrists, feet, toes, back# fatigue, migraine headache for 15 days after the first dose. For second dose, same symptoms continuously for 11 days now and low grade fevers, chilled for first 4 days after the vaccine and on the 11th and 12th days after the second dose. No treatment received for events and The patient was not diagnosed with COVID-19 prior to vaccination, and Since the vaccination, the patient has not been tested for COVID-19. Outcome for events was not recovered.   Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021377679 Same patient/drug, diff event sep for different doses.
Earache; Mild headache; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Mar2021 at 16:00 (at the age of 49-year-old), as a single dose for COVID-19 immunisation. The patient's medical history was unknown. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received oseltamivir phosphate (TAMIFLU) and sulfur (MANUFACTURER UNKNOWN); both for unspecified indications from unknown dates and experienced drug allergy. On 02Mar2021 at 17:15, the patient experienced earache and mild headache. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events earache and mild headache was recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
tongue is painful; bumps are inflamed; splotchy; red spots on the injection iste; arm pain; swelling; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), PERIPHERAL SWELLING (swelling), GLOSSODYNIA (tongue is painful), INFLAMMATION (bumps are inflamed) and RASH (splotchy) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain) and PERIPHERAL SWELLING (swelling). On 25-Mar-2021, the patient experienced GLOSSODYNIA (tongue is painful), INFLAMMATION (bumps are inflamed), RASH (splotchy) and VACCINATION SITE ERYTHEMA (red spots on the injection iste). At the time of the report, PAIN IN EXTREMITY (arm pain), PERIPHERAL SWELLING (swelling), GLOSSODYNIA (tongue is painful), INFLAMMATION (bumps are inflamed), RASH (splotchy) and VACCINATION SITE ERYTHEMA (red spots on the injection iste) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Tylenol XR.
This medically confirmed spontaneous report (initial receipt 06-Jun-2013) concerns a female patient with a medical history of diabetes and allergies to amoxicillin, carisoprodol and sulfa. On an unspecified date 'years ago', the patient received a influenza vaccine (batch and brand unspecified). After this, on an unspecified date, the patient almost went blind. Then the patient took a medicine which restored her sight. The event outcome was recovered.
Patient for 2 days following vaccine has developed  reoccurring hives on upper thighs that goes away at night but reappeared for 2 days after the shot but did not experience anything on the third day
Information has been received from a health professional concerning a 41 month old white male who on 10/09/2002 was vaccinated with a second dose of varicella virus vaccine live.  It was noted that the vaccine was given at the health department so the reporter did not have the lot number.  On 01/31/2005 the patient broke out with chickenpox.  No additional information was provided.  Additional information has been requested.
took 3rd capsule & had stomach cramps for 2 1/2 days, but cramps are diminishing;
I had congestion, coughing, sore throat and postnasal drip. I also had a headache. I took a COVID-19 home test on February 16, 2023, and it was positive. I contacted my doctor and he prescribed PAXLOVID. I was only able to take it for 1 day as I was not able to tolerate the taste and it caused me severe diarrhea. I took TYLENOL. My symptoms improved over a weeks' time. It took me a week and a half for it to be all gone.
Pale in hand immediately after shot. Was cranky and fussy in PM after shot.  About 10 or 11 hours later became cranky again.  Put him down and he became very pale. Paleness lasted 2 - 3 mins.  A little less activity at that time.  Did not seem as alert during the episdoe. Not unresponsive.
Information was received from a lawyer regarding a case in litigation involving a male patient, age and medical history not provided. In 2010 the patient was inoculated with ZOSTAVAX vaccine for routine adult health maintenance and the prevention of shingles. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. Later in 2010 the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX or despite receiving ZOSTAVAX for prevention of shingles, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain, suffering and other damages. Additional information has been requested.
He test results came back positive for Covid-19; Lack of drug effect; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Sep-2021 and was forwarded to Moderna on 24-Sep-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (He test results came back positive for Covid-19) and DRUG INEFFECTIVE (Lack of drug effect) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Sep-2021, the patient experienced SARS-COV-2 TEST POSITIVE (He test results came back positive for Covid-19) and DRUG INEFFECTIVE (Lack of drug effect). At the time of the report, SARS-COV-2 TEST POSITIVE (He test results came back positive for Covid-19) and DRUG INEFFECTIVE (Lack of drug effect) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Sep-2021, SARS-CoV-2 test: positive (Positive) Positive.         It was reported that patient has mild symptoms. No relevant concomitant medications were reported. No treatment information was reported.; Sender's Comments: This case concerns a 63-year-old male patient with no reported medical, who experienced SARS-CoV-2 test positive and Drug ineffective 3 months, 28 days after the second dose of Spikevax. The reporter did not provide causality assessment. The rechallenge was not applicable The benefit-risk relationship of Spikevax in not affected by this report.
This spontaneous report as received from a physician refers to a 8 week old female patient. No pertinent medical history, no concomitant medication and no drug reactions/allergies with the patient. On 17-FEB-2014 the patient was vaccinated with ROTATEQ (lot# reported as J008739, exp 25-MAR-2015) (dose, route, dose# unknown). Other suspect therapies included RECOMBIVAX HB (lot# reported as J004700, exp 26-DEC-2015) on 17-FEB-2014 (dose, route, dose# unknown). Concomitant therapies included PENTACEL and PREVENAR 13 on 17-FEB-2014 (dose, route, dose# unknown). On 17-FEB-2014, after the administration of the vaccines the patient experienced four watery stools and a fever of 100.1. On 18-FEB-2014 the patient experienced another 3 watery stools. The patient's parents brought her back to the physician's office to be evaluated; the physician diagnosed the patient with "diarrhea of moderate severity" and recommended hydration and probiotics to treat the patient. No labs performed due to the events. The outcome was unknown. Action taken was not provided. Additional information has been requested.